Truist downgraded V2X (VVX) to Hold from Buy with an unchanged price target of $65. The firm cites valuation for the downgrade with the shares up 20% over the past month. Truist sees limited share upside from current levels. V2X is less exposed to potential One Big Beautiful Bill upside than Truist’s favorite name CACI (CACI(, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VVX:
- V2X price target raised to $69 from $62 at Citi
- V2X wins SHIELD IDIQ contract from MDA
- V2X expands board with experienced defense industry leaders
- Trump Trade: 350 drugs to see price raises despite President’s pressure
- General Dynamics, Northrop Grumman and others awarded on $25.36B DMEA contract